Literature DB >> 10722255

Mortality in a cohort of Norwegian patients with rheumatoid arthritis followed from 1977 to 1992.

A G Kvalvik1, M A Jones, D P Symmons.   

Abstract

This study aimed to describe the mortality pattern of Norwegian patients with rheumatoid arthritis (RA). The subjects were 149 patients (52 males(M)) who were discharged from a Norwegian rheumatology hospital in 1977 after their first admission for RA. 126 patients (85%) met the 1958 criteria for definite or classical RA. By the end of 1992, 2 patients, both with definite/classical RA, were lost to follow-up. Of the remaining 147 patients (51M), 68 (25M) had died. The overall standardised mortality ratio (SMR) was 149 (95% CI: 115-188). The mortality was significantly raised for females with SMR= 168 (120-223). The moderate increase in the male SMR of 126 (81-181) was restricted to the early years of follow up. Patients with definite/classical RA had a somewhat higher SMR (159 (120-202)). Excess deaths were due to malignant disease in males and cardiovascular disease in females. RA was mentioned on one third of the death certificates. This study supports previous findings that patients with RA have a reduced long term survival, most prominent in females.

Entities:  

Mesh:

Year:  2000        PMID: 10722255     DOI: 10.1080/030097400750001770

Source DB:  PubMed          Journal:  Scand J Rheumatol        ISSN: 0300-9742            Impact factor:   3.641


  21 in total

1.  Patterns of cardiovascular risk in rheumatoid arthritis.

Authors:  D H Solomon; N J Goodson; J N Katz; M E Weinblatt; J Avorn; S Setoguchi; C Canning; S Schneeweiss
Journal:  Ann Rheum Dis       Date:  2006-06-22       Impact factor: 19.103

Review 2.  The role of endothelial function and its assessment in rheumatoid arthritis.

Authors:  Faisel Khan; Bernat Galarraga; Jill J F Belch
Journal:  Nat Rev Rheumatol       Date:  2010-03-30       Impact factor: 20.543

3.  Heart rate variability in familial Mediterranean fever patients.

Authors:  Hakan Kaya; Arif Süner; Sedat Köroğlu; Ahmet Akçay; İbrahim Halil Türkbeyler; Murat Köleoğlu
Journal:  Eur J Rheumatol       Date:  2014-06-01

Review 4.  Targeting cardiovascular risk in rheumatoid arthritis: a dual role for statins.

Authors:  Radjesh J Bisoendial; Erik S G Stroes; John J P Kastelein; Paul Peter Tak
Journal:  Nat Rev Rheumatol       Date:  2010-02-09       Impact factor: 20.543

5.  Mortality in patients with rheumatoid arthritis treated actively from the time of diagnosis.

Authors:  R Peltomaa; L Paimela; H Kautiainen; M Leirisalo-Repo
Journal:  Ann Rheum Dis       Date:  2002-10       Impact factor: 19.103

Review 6.  Cardiovascular morbidity and mortality in rheumatoid arthritis.

Authors:  Sherine E Gabriel
Journal:  Am J Med       Date:  2008-10       Impact factor: 4.965

7.  Causes of death in patients with rheumatoid arthritis autopsied during a 40-year period.

Authors:  R Koivuniemi; L Paimela; R Suomalainen; H Piirainen; M Karesoja; T Helve; M Leirisalo-Repo
Journal:  Rheumatol Int       Date:  2008-08-21       Impact factor: 2.631

8.  Assessment of left atrial function using speckle tracking echocardiography in ankylosing spondylitis: a case-control study.

Authors:  Murathan Kucuk; Necmettin Korucuk; Veysel Tosun; Mediha Cavusoglu; İbrahim Basarici
Journal:  Int J Cardiovasc Imaging       Date:  2018-07-16       Impact factor: 2.357

9.  Prevalence of cardiovascular disease and major risk factors in patients with rheumatoid arthritis: a multinational cross-sectional study.

Authors:  Dimitrios A Pappas; Fredrik Nyberg; Joel M Kremer; Kathy Lampl; George W Reed; Laura Horne; Meilien Ho; Alina Onofrei; Anand N Malaviya; Oscar L Rillo; Sebastiao C Radominski; Janos Gal; Allan Gibofsky; Tatiana V Popkova; Leda Laurindo; Eduardo M Kerzberg; Roman Zahora; Bernado A Pons-Estel; Jeffrey R Curtis; Daniel E Furst; Jeffrey D Greenberg
Journal:  Clin Rheumatol       Date:  2018-04-25       Impact factor: 2.980

Review 10.  Epidemiological studies in incidence, prevalence, mortality, and comorbidity of the rheumatic diseases.

Authors:  Sherine E Gabriel; Kaleb Michaud
Journal:  Arthritis Res Ther       Date:  2009-05-19       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.